SCHEMBL6764283

SCHEMBL6764283

COc1cccc(-n2cc(OC)oc2=O)c1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 1/20 0.49
ALDH1A1 P00352 5/20 0.46
KDM4E B2RXH2 3/20 0.46
HPGD P15428 1/20 0.46
TSHR P16473 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
MAPT P10636 2/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
RAB9A P51151 2/20 0.44
PKM P14618 1/20 0.43
LMNA P02545 1/20 0.43
POLB P06746 1/20 0.43
TP53 P04637 1/20 0.42
XDH P47989 1/20 0.42
FGFR1 P11362 1/20 0.42
CYP1A2 P05177 1/20 0.42
NPC1 O15118 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6760765 0.83 KDM4E (0.41) MGLLALDH1A1KDM4EHPGDMEN1
SCHEMBL6759687 0.82 L3MBTL1 (0.49) MGLLALDH1A1KDM4EHPGDMAPT
SCHEMBL18050078 0.70 MGLL (0.54) MGLLALDH1A1KDM4EHPGDTSHR
SCHEMBL3301674 0.70 ALDH1A1 (0.62) MGLLALDH1A1KDM4EHPGDTSHR
SCHEMBL11240303 0.69 L3MBTL1 (0.74) MGLLALDH1A1KDM4ESMN1; SMN2MAPT
SCHEMBL16474662 0.69 ALDH1A1 (0.49) MGLLALDH1A1KDM4EHPGDTSHR
SCHEMBL16474692 0.68 BRD4 (0.56) MGLLALDH1A1KDM4EHPGDTSHR
SCHEMBL16474678 0.67 BRD4 (0.58) MGLLALDH1A1KDM4EHPGDTSHR
SCHEMBL19331190 0.67 COMT (0.66) MGLLALDH1A1KDM4EHPGD
SCHEMBL10973851 0.67 MGLL (0.50) MGLLALDH1A1KDM4EHPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6723860-B2 7a-alkoxy-4H-pyrano[3,2-d]-oxazol-2(3H)-one and process for producing the same UBE INDUSTRIES, LTD. (JP) 2004-04-20 US disclosed
EP-1207162-B1 7a-alkoxy-4H-pyrano-[3,2-d]-oxazol-2(3H)-one and process for producing the same UBE INDUSTRIES (JP) 2004-02-25 EP disclosed
US-20020072612-A1 7a-alkoxy-4H-pyrano [3,2-d] -oxazol-2 (3H) -one and process for producing the same UBE INDUSTRIES, LTD. (JP) 2002-06-13 US disclosed
EP-1207162-A1 7a-alkoxy-4H-pyrano-[3,2-d]-oxazol-2(3H)-one and process for producing the same Ube Industries, Ltd. (JP) 2002-05-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020072612-A1 7a-alkoxy-4H-pyrano [3,2-d] -oxazol-2 (3H) -one and process for producing the same ACSL1, ACSL4, ACSL3 MGLL 87/4885ALDH1A1 11/4885KDM4E 2201/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.